Inactive Instrument
Canntab Therapeutics Limited Stock
Stocks
CTABF
CA1377991023
Pharmaceuticals
OTC Markets Traded| 1 day | -99.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 2020-05-14 | |
Frank Candido
IRC | Investor Relations Contact | 61 | 2018-08-31 |
Eric Malinski
SAM | Sales & Marketing | - | 2018-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/6/24 | Option | Director | 100,000 | 0.2570% | ||
| 2/6/24 | Option | Director | 100,000 | 0.2570% | ||
| 2/22/22 | Sell | Chief Executive Officer | 400,000 | 1.0717% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | -.--% | - | - | 38 | |
| -2.90% | -2.31% | -12.94% | -6.07% | 13.25B | |
| -1.14% | +0.52% | -31.65% | -56.89% | 4.77B | |
| -1.95% | -0.24% | -4.69% | -7.44% | 4.29B | |
| -2.07% | -0.39% | -5.43% | -35.02% | 3.77B | |
| -0.73% | +1.80% | -20.50% | +1.53% | 3.49B | |
| -0.65% | -3.10% | -2.40% | -7.04% | 3.35B | |
| -1.51% | -1.30% | -14.23% | -0.36% | 3.04B | |
| -1.09% | -0.07% | -22.02% | -19.02% | 2.24B | |
| -0.87% | +0.05% | -25.75% | -24.39% | 1.64B | |
| Average | -11.19% | -0.56% | -15.51% | -17.19% | 4.43B | |
| Weighted average by Cap. | -1.84% | -0.97% | -14.49% | -15.50% |
Employees
-
Sector
Pharmaceuticals
